Clinical Trials for Unresectable Solid Neoplasm

Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression

NCT ID: NCT04957615

This clinical trial is studying a medication called nivolumab to see how well it works for patients with certain types of advanced cancer. Specifically, it's focused on patients whose tumors have s...